JP2017530185A5 - - Google Patents

Download PDF

Info

Publication number
JP2017530185A5
JP2017530185A5 JP2017518989A JP2017518989A JP2017530185A5 JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5 JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017518989 A JP2017518989 A JP 2017518989A JP 2017530185 A5 JP2017530185 A5 JP 2017530185A5
Authority
JP
Japan
Prior art keywords
methyl
dichlorophenyl
dihydroisoquinolin
ethanone
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017518989A
Other languages
English (en)
Japanese (ja)
Other versions
JP6622299B2 (ja
JP2017530185A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/073053 external-priority patent/WO2016055479A1/en
Publication of JP2017530185A publication Critical patent/JP2017530185A/ja
Publication of JP2017530185A5 publication Critical patent/JP2017530185A5/ja
Application granted granted Critical
Publication of JP6622299B2 publication Critical patent/JP6622299B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017518989A 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体 Active JP6622299B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14188174.8 2014-10-08
EP14188174 2014-10-08
PCT/EP2015/073053 WO2016055479A1 (en) 2014-10-08 2015-10-06 Tetrahydroisoquinoline derivatives

Publications (3)

Publication Number Publication Date
JP2017530185A JP2017530185A (ja) 2017-10-12
JP2017530185A5 true JP2017530185A5 (cg-RX-API-DMAC10.html) 2019-10-03
JP6622299B2 JP6622299B2 (ja) 2019-12-18

Family

ID=51790569

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017518989A Active JP6622299B2 (ja) 2014-10-08 2015-10-06 テトラヒドロイソキノリン誘導体

Country Status (18)

Country Link
US (1) US10105359B2 (cg-RX-API-DMAC10.html)
EP (1) EP3204359B1 (cg-RX-API-DMAC10.html)
JP (1) JP6622299B2 (cg-RX-API-DMAC10.html)
CN (1) CN107001278B (cg-RX-API-DMAC10.html)
BR (1) BR112017007123B1 (cg-RX-API-DMAC10.html)
CA (1) CA2963951C (cg-RX-API-DMAC10.html)
CY (1) CY1123417T1 (cg-RX-API-DMAC10.html)
DK (1) DK3204359T3 (cg-RX-API-DMAC10.html)
EA (1) EA035544B1 (cg-RX-API-DMAC10.html)
ES (1) ES2821821T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20201469T1 (cg-RX-API-DMAC10.html)
HU (1) HUE050664T2 (cg-RX-API-DMAC10.html)
LT (1) LT3204359T (cg-RX-API-DMAC10.html)
PL (1) PL3204359T3 (cg-RX-API-DMAC10.html)
PT (1) PT3204359T (cg-RX-API-DMAC10.html)
RS (1) RS60933B1 (cg-RX-API-DMAC10.html)
SI (1) SI3204359T1 (cg-RX-API-DMAC10.html)
WO (1) WO2016055479A1 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108884077A (zh) * 2016-02-25 2018-11-23 阿森纽荣股份公司 糖苷酶抑制剂
CA3018352A1 (en) 2016-04-13 2017-10-19 Ucb Biopharma Sprl Tetrahydroisoquinoline derivatives
CN107698433A (zh) * 2017-09-12 2018-02-16 潍坊滨海石油化工有限公司 苯乙酸的制备方法
DK3717025T3 (da) 2017-12-01 2021-11-22 UCB Biopharma SRL Billeddannende midler
TWI725408B (zh) * 2018-04-20 2021-04-21 美商美國禮來大藥廠 多巴胺d1受體正向異位調節劑
US12358890B2 (en) 2019-07-01 2025-07-15 UCB Biopharma SRL Substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator
IL289314B2 (en) * 2019-07-01 2025-09-01 UCB Biopharma SRL Tetrahydroisoquinoline derivative is transformed as a positive allosteric modulator d1
KR20230014706A (ko) * 2020-04-24 2023-01-30 더 리전츠 오브 더 유니버시티 오브 캘리포니아 Nurr1 수용체 조절제 및 이의 용도
CN111943930B (zh) * 2020-08-25 2022-11-01 南京三元阳普医药科技有限公司 Lasmiditan的合成工艺
JP7591138B2 (ja) * 2020-10-07 2024-11-27 イーライ リリー アンド カンパニー ドーパミンd1受容体ポジティブアロステリック調節因子としてのフェニル-3,4-ジヒドロイソキノリン-2(1h)-イル-エタン-1-オン誘導体
EP4267555A1 (en) * 2020-12-03 2023-11-01 UCB Biopharma SRL Octahydroisoquinolinyl derivatives
CN116685308A (zh) * 2020-12-18 2023-09-01 Ucb生物制药有限责任公司 无定形固体分散体
JP7777589B2 (ja) 2020-12-18 2025-11-28 ユーシービー バイオファルマ エスアールエル ジヒドロイソキノリニル誘導体
WO2022129356A1 (en) * 2020-12-18 2022-06-23 UCB Biopharma SRL Prodrugs of 2-(3,5-dichloro-1-methyl-indazol-4-yl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(1-hydroxy-1-methyl-ethyl)-1-methyl-3,4-dihydro-1h-isoquinolin-2-yl]ethanone
LT4263517T (lt) * 2020-12-18 2025-01-10 UCB Biopharma SRL Pakeistasis tetrahidroizochinolino darinys kaip d1 teigiamas alosterinis moduliatorius
JP2024509448A (ja) 2021-03-08 2024-03-01 イーライ リリー アンド カンパニー 幻覚及び認知症に関連する精神病の治療におけるメビダレン及び他のd1陽性アロステリックモジュレーターの使用
BR112023018196A2 (pt) 2021-03-09 2023-12-12 Lilly Co Eli Uso de mevidalen e outros moduladores alostéricos positivos d1 para retardar a progressão da doença de parkinson
CN114671810B (zh) * 2022-03-21 2024-03-22 济南鸿湾生物技术有限公司 一种咪唑苯脲的制备方法
CN115611768B (zh) * 2022-11-14 2024-03-05 郑州大学 一种3,4-二氯苯腈的合成方法
CN118724764B (zh) * 2024-06-07 2025-11-18 绍兴文理学院 一种芳基伯磺酰胺类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766131A (en) * 1980-10-17 1988-08-23 Pennwalt Corporation 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics
IL162310A0 (en) * 2001-12-19 2005-11-20 Lundbeck & Co As H 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
ATE459618T1 (de) * 2004-04-29 2010-03-15 Aventis Pharma Inc 3-piperidinylisochroman-5-ole als dopaminagonisten
EP2125741A1 (en) * 2007-03-01 2009-12-02 Janssen Pharmaceutica, N.V. Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor

Similar Documents

Publication Publication Date Title
JP2017530185A5 (cg-RX-API-DMAC10.html)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2016517878A5 (cg-RX-API-DMAC10.html)
RU2606497C2 (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
ES2629414T3 (es) Derivados de tiazol
JP2021500345A5 (cg-RX-API-DMAC10.html)
RU2018140092A (ru) Новые пиразолпиримидиновые производные
JP2020506946A5 (cg-RX-API-DMAC10.html)
HRP20210143T1 (hr) 2-heteroaril-3-okso-2,3-dihidropiridazin-4-karboksamidi za liječenje raka
JP2014506599A5 (cg-RX-API-DMAC10.html)
JP2010510319A5 (cg-RX-API-DMAC10.html)
JP2016523911A5 (cg-RX-API-DMAC10.html)
JP2017503837A5 (cg-RX-API-DMAC10.html)
JP2016513660A5 (cg-RX-API-DMAC10.html)
JP2017511794A5 (cg-RX-API-DMAC10.html)
HRP20130106T1 (hr) Imidazotriazini i imidazopirimidini kao inhibitori kinaze
JP2019513776A5 (cg-RX-API-DMAC10.html)
JP2014526549A5 (cg-RX-API-DMAC10.html)
JP2019508384A (ja) 5−置換2−(モルホリン−4−イル)−1,7−ナフチリジン
JP2019523233A5 (cg-RX-API-DMAC10.html)
JP2018511587A5 (cg-RX-API-DMAC10.html)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
HRP20171670T1 (hr) Spojevi i sastavi za moduliranje egfr-aktiviteta
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2015523390A (ja) 置換型ピラゾロン化合物及び使用方法